Marinomed Biotech AG

0
WBO:MARI (Austria)  
€ 8.50 (+5.72%) Oct 28
At Loss
Market Cap:
€ 13.10M ($ 14.16M)
Enterprise V:
€ 32.98M ($ 35.67M)
Volume:
1.46K
Avg Vol (2M):
2.42K
Trade In:

Business Description

Description
Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generated from the virology segment.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.09
Equity-to-Asset -0.98
Debt-to-Equity -1.84
Debt-to-EBITDA -4.75
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.86
Distress
Grey
Safe
Beneish M-Score -3.18
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 44.81
9-Day RSI 43.38
14-Day RSI 46.9
6-1 Month Momentum % -45.83
12-1 Month Momentum % -74.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.87
Quick Ratio 1.46
Cash Ratio 0.72
Days Inventory 72.17
Days Sales Outstanding 148.42
Days Payable 50.6

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.1
Shareholder Yield % 7.15

Financials

WBO:MARI's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Marinomed Biotech AG Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 6.603
EPS (TTM) (€) -4.513
Beta -0.22
Volatility % 110.45
14-Day RSI 46.9
14-Day ATR (€) 0.761544
20-Day SMA (€) 9.042
12-1 Month Momentum % -74.52
52-Week Range (€) 2 - 39.2
Shares Outstanding (Mil) 1.54

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Marinomed Biotech AG Filings

Filing Date Document Date Form
No Filing Data

Marinomed Biotech AG Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Marinomed Biotech AG Frequently Asked Questions

What is Marinomed Biotech AG(WBO:MARI)'s stock price today?
The current price of WBO:MARI is €8.50. The 52 week high of WBO:MARI is €39.20 and 52 week low is €2.00.
When is next earnings date of Marinomed Biotech AG(WBO:MARI)?
The next earnings date of Marinomed Biotech AG(WBO:MARI) is .
Does Marinomed Biotech AG(WBO:MARI) pay dividends? If so, how much?
Marinomed Biotech AG(WBO:MARI) does not pay dividend.

Press Release

Subject Date
No Press Release